Silvia Rodrigues, PhD student at Exogenus Therapeutics, presented a poster with results on research and development work done on the automatization of cord blood processing for production of an exosome-based medicinal product and its relevance for the scaling up of clinical-grade manufacturing process.

Held in Coimbra in February 2018, the 1st Meeting on Vesicular Biology of University of Coimbra, brought together scientists with expertise in different areas of vesicular biology, stimulating an integrative debate around extracellular vesicles, autophagy, endocytosis, intracellular trafficking, and others:

Exogenus is one of few companies worldwide working on the development of exosome-based products for therapeutic use.

Silvia Rodrigues_Poster

Co-funded by Centro 2020 – Regional Operational Program, Portugal 2020 and European Union through FEDER.